• 천문학회지
• /
• 제31권2호
• /
• pp.117-125
• /
• 1998

We have observed the 10-9 transitions of $HC_3N$ and its $^{13}C$ substitutes ($H^{13}CCCN,\;HC^{13}CCN$, and $HCC^{13}CN$), and the vibration ally excited 12-11 ($v_r=1$) $HC_3N$ transition toward the Sgr B2 molecular cloud. The observed $HC_3N$ emission shows an elongated shape around the Principal Cloud ($\~$4.5 pc in R.A. $\times$ 7.4 pc in Decl.). The optically thin $H^{13}CCCN$ line peaks around the (N) core and we derive the total column density $N(H^{13}CCCN) = 4 {\times}10^{13} cm^{-2}$ at this position. Toward the 2' N cloud which shows the peculiar chemistry, the $HC_3N$ lines show enhancements compared to the extended envelope. The shocks of the 2' N may have resulted in the enhancement of $HC_3N$. The hot component of $HC_3N$ is strongly concentrated around the (N) core and its HPW is $\~$0.9 pc in diameter. We derive the lower limit of the abundance ratio $N(HC_3N)/N(H^{13}CCCN)$ to be larger than 40 in most regions except the (M) and (N) cores. The fractionation processes of $^{13}C $at this region may not be as effective as previously reported.

• 약학회지
• /
• 제57권1호
• /
• pp.43-54
• /
• 2013

Viral hepatitis is the inflammation of liver cells caused by viruses, and still one of the major health-care problems worldwide. A number of viruses to cause hepatitis are type A, B, C, D, E or G. Among these viruses leading to hepatitis, B and C are more troublesome being more prone to chronic illness which can cause the potentially fatal conditions of hepatocellular carcinoma (HCC) and/or liver failure. If immediate treatment is not initiated, liver transplant is the only option left. Over the past few decades there has been remarkable progress in diagnose and monitor all hepatitis virus infections for treatment and prevention. Nonetheless, important challenges remain to develop more effective and safe vaccines for prevention as well as antiviral agents to reduce viremia/viral load by inhibiting viral replication. The development and evaluation of antiviral agents through carefully designed clinical trials over the last 25 years has heralded a new dawn in the treatment of patients chronically infected with the hepatitis B and C viruses, but not so for the D virus. The introduction of Direct Acting Antivirals (DDAs) for the treatment of HBV carriers has permitted the long term use of these compounds for the continuous suppression of viral replication. This review aims to summarize the current status and development approaches of antiviral drugs for the treatment of viral hepatitis and future perspectives.

• Biomolecules & Therapeutics
• /
• 제30권6호
• /
• pp.585-592
• /
• 2022

Treatment of triple-negative breast cancer (TNBC) has been limited due to the lack of molecular targets. In this study, we evaluated the cytotoxicity of hydroxyzine, a histamine H1 receptor antagonist in human triple-negative breast cancer BT-20 and HCC-70 cells. Hydroxyzine inhibited the growth of cells in dose- and time-dependent manners. The annexin V/propidium iodide double staining assay showed that hydroxyzine induced apoptosis. The hydroxyzine-induced apoptosis was accompanied down-regulation of cyclins and CDKs, as well as the generation of reactive oxygen species (ROS) without cell cycle arrest. The effect of hydroxyzine on the induction of ROS and apoptosis on TNBC cells was prevented by pre-treatment with ROS scavengers, N-acetyl cysteine or Mito-TEMPO, a mitochondria-targeted antioxidant, indicating that an increase in the generation of ROS mediated the apoptosis induced by hydroxyzine. Western blot analysis showed that hydroxyzine-induced apoptosis was through down-regulation of the phosphorylation of JAK2 and STAT3 by hydroxyzine treatment. In addition, hydroxyzine induced the phosphorylation of JNK and p38 MAPK. Our results indicate that hydroxyzine induced apoptosis via mitochondrial superoxide generation and the suppression of JAK2/STAT3 signaling.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권2호
• /
• pp.915-921
• /
• 2013

Background: Hepatocellular carcinoma is one of the leading causes of mortalities worldwide. The search for new therapeutic targets is of utmost importance for improved treatment. Altered expression of HDAC1 in hepatocellular carcinoma (HCC) and its requirement for liver formation in zebrafish, suggest that it may regulate key events in liver carcinogenesis and organogenesis. However, molecular mechanisms of HDAC1 action in liver carcinogenesis are largely unknown. The present study was conducted to identify HDAC1 interacting proteins in HepG2 cells using modified SH-double-affinity purification coupled with liquid mass spectrophotemetery. Materials and Methods: HepG2 cells were transfected with a construct containing HDAC1 with a C-terminal strepIII-HA tag as bait. Bait proteins were confirmed to be expressed in HepG2 cells by western blotting and purified by double affinity columns and protein complexes for analysis on a Thermo LTQ Orbitrap XL using a C18 nano flow ESI liquid chromatography system. Results: There were 27 proteins which showed novel interactions with HDAC1 identified only in this study, while 14 were among the established interactors. Various subunits of T complex proteins (TCP1) and prefoldin proteins (PFDN) were identified as interacting partners that showed high affinity with HDAC1 in HepG2 cells. Conclusions: The double affinity purification method adopted in this study was very successful in terms of specificity and reproducibility. The novel HDAC1 complex identified in this study could be better therapeutic target for treatment of hepatocellular carcinoma.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권12호
• /
• pp.6363-6368
• /
• 2012

Objective: The study aim was to prepare poly-DL-lactide-poly (PELA) microspheres encapsulating recombinant tissue inhibitors of metalloproteinase-1 (TIMP-1) in an adenovirus to investigate its inhibition on the proliferation of hepatocellular carcinoma cells HepG2. Methods: Microspheres were prepared by encapsulating the recombinant TIMP-1 adenovirus into biodegradable PELA. The particle size, viral load, encapsulation efficiency and in-vitro release were measured. Microspheres were used to infect HepG2 cells, then infection efficiency was examined under a fluorescent microscope and ultrastructural changes assessed by TEM. Expression of TIMP-1 mRNA in HepG2 cells was examined by semi-quantitative RT-PCR and proliferation by MTT and cell growth curve assays. Results: We successfully prepared microspheres encapsulating recombinant TIMP-1 adenovirus with a diameter of $1.965{\mu}m$, an encapsulation efficiency of 60.0%, a viral load of $10.5{\times}10^8/mg$ and approximate 60% of virus release within 120 h, the total releasing time of which was longer than 240 h. The microspheres were confirmed to be non-toxic with blank microspheres. Infected HepG2 cells could stably maintain in-vitro expression of TIMP-1, with significantly effects on biological behaviour Conclusion: PELA microspheres encapsulating a recombinant TIMP-1 adenovirus can markedly inhibit the proliferation of HepG2 cells, which provides an experimental basis for polymer/chemistry-based gene therapy of hepatocellular carcinomas.

• 대한방사선기술학회지:방사선기술과학
• /
• 제20권2호
• /
• pp.73-78
• /
• 1997

The goal of this paper is that we know the usefulness of echo-planar imaging(EPI) for discriminate between hepatocellular carcinoma(HCC) and hemangioma. We get a time signal intensity curve for liver diseases from the dynamic contrast enhancement images and compared and analyze both the contrast ratio(CR) and the contrast to noise ratio(CNR) using echo planar imaging. The obtained results are follows : 1. Hepatocellular carcinoma was shown the best contrast after about 20 seconds when Is the earlist time in the main artery, and then reduced. The center where is disease was shown the characteristic that the best contrast is appeared after about 35-45 seconds and then slowly reduced. Liver parenchyma was shown the best contrast and reduced after 60 seconds. 2. The peripheral nodular of hemangioma was shown the better contrast soon. On the other hend, the contrast of center where is disease started to increase after 60 seconds and was equal to that of liver parenchyma. Increasing of the contrast continued after. 3. Turbo SE technic was used, the average of CR for hepatocellular carcinoma was $36.7{\pm}1.2$ and the average of CNR was $2.4{\pm}3.2$, while the average of CNR for hemangioma was $54.9{\pm}1.0$ and the average of CNR was $9.7{\pm}1.3$. 4. EPI technic was used, the average of CR for hepatocellular carcinoma was $47.8{\pm}1.2$ and the average of CNR was $3.4{\pm}2.1$, while the average of CNR for hemangioma was $75.7{\pm}2.2$ and the average of CNR was $9.5{\pm}1.1$. According to above we can find that hemangioma is more bright than hepatocellular carcinoma and the difference of brightness between hepatocellular carcinoma and hemangioma is useful sequence.

• 한국유기농업학회지
• /
• 제22권3호
• /
• pp.503-519
• /
• 2014

녹비작물로서 녹비보리와 헤어리베치를 환원하고, 토양개량제로서 charcoal을 시용하여 생강연작 재배지에서 생강을 재배한 결과, 토양 pH가 시험 전 6.9~8.1에서 수확 후 6.8~7.6로 감소하였으며, 전기전도도(electrical conductivity, EC)는 한 시험 전 $0.45{\sim}1.25dSm^{-1}$에서 수확 후 $0.30{\sim}0.61dSm^{-1}$로 감소하였다. 토양유기물(soil organic matter, SOM) 함량과 토양 중 총질소(total-nitrogen, T-N) 함량은 증가하였다. 유효인산 함량과 치환성 K, Ca, Mg 함량은 유의성 있는 차이가 나타나지 않았다. 그러나, 토양 pH를 중성화시키고, EC 경감, SOM과 T-N 함량의 증가는 토양 화학성 변화에 있어 긍정적으로 평가할 수 있다. 생강양분의 함량적 차이를 정상근과 이병근의 함량 차이, 토양의 점토함량 별 양분 함량 차이로 조사한 결과, 유의성이 있는 결과를 얻었으며, 처리구별로 차이가 있는 것으로 나타났다. 특히, 망간(manganese, Mn)의 경우, 이병근의 지하부에서 3~4배 정도 높은 것으로 나타났는데, 망간(Mn)은 식물 뿌리에 대한 독성 작용으로 뿌리를 갈변시키고 균열을 일으키는 것으로 보고된바, 뿌리썩음병의 발생으로 Mn이 작용하여 이병근의 Mn 함량이 높은 것으로 보인다. 따라서, 뿌리썩음병과 Mn의 상관관계를 밝히는 추가 연구가 필요할 것으로 판단된다. 또한, 생강 수확 후 생강 생육 상태와 생산량을 조사한 결과, 녹비보리, 헤어리베치, 녹비보리+charcoal, 헤어리베치+charcoal을 처리한 시험구(Plot 2, Plot 3, Plot 4, Plot 5)에서 생강의 생육상태가 양호하고 생산량이 높아 병발생률이 상대적으로 낮게 나타났다. 특히, Plot 4(헤어리베치+charcoal)-LCC에서는 100%의 생산량을 보였다. 녹비작물과 charcoal의 처리가 생강생육과 생산에 있어 긍정적인 영향을 미친 것으로 판단된다. 그리고, 상대적으로 점토함량이 낮은 처리구가 점토함량이 높은 처리구보다 생육 상태와 생산량에서 우세하였는데, 모래와 점토 함량 차이에 따른 배수와 토양의 수분보유력이 생강생육에 큰 영향을 준 것으로 판단된다.

• 한국식품저장유통학회지
• /
• 제16권1호
• /
• pp.122-127
• /
• 2009

어성초가 자연발효에 의존할 경우 잡균 및 산막효모의 오염 및 발효기간이 오래 걸린다는 단점이 있다. 본 연구는 전통적인 방법으로 발효된 어성초 엑기스에서 야생효모를 분리하고, 어성초 추출물에서의 발효 특성을 검토하였다. 그 결과, $15^{\circ}Brix$ 당용액에서 알코올 함량은 배양시간이 길어질수록 증가하여 배양 90시간째에 HCE 12%, HCD 11.2%, HCA 10.5% 순으로 높았다. HCF, HCG, HCB, HCC는 알코올 함량이 $7.5{\sim}8.5%$ 사이였다. 당용액에서 알코올 생성능이 가장 높은 HCE와 HCD 균주를 어성초 분리효모로 선정하고, 어성초배지(어성초 착즙액:증류수(1:1)에서 기존 Saccharomyces 균주와 발효력 비교 검토 결과, pH는 발효 전 $4.09{\sim}4.12$에서 발효 후 $3.57{\sim}3.78$로, 당도는 발효전 $15.00{\sim}15.19$에서 $7.75{\sim}9.57$로 감소하였다. 산도는 발효전 $0.138{\sim}0.210$에서 발효 후 $0.282{\sim}0.450$으로 증가하였으며, 알코올 함량은 발효 후 $3.6{\sim}4.6$으로 어성초 분리균인 HCD와 HCE가 감, 사과 및 포도에서 분리한 DJ97, YJK, R12, RCY 보다 소폭 높았다. 발효된 어성초배양액은 어성초 특유의 강한 비린내가 감소하고 생성된 알코올로 인해향은 보통 수준 이상의 관능평가를 얻었으나, 맛은 보통 이하로 낮은 관능평가를 얻었다. 색은 최저 $4.75{\pm}1.44$, 최고 $6.85{\pm}1.63$으로 HCE가 관능항목 중 가장 높은 점수를 얻었다. 전반적인 기호도는 최저 $3.95{\pm}1.17$, 최고 $5.00{\pm}1.41$로 보통의 수준으로 이는 맛의 기호도가 충족되지 못하여 낮은 관능평가를 얻은 것으로 사료된다. 그러나, 색, 향, 맛, 전반적인 기호도에서 균주간의 유의성(p<0.05)은 인정되지 않았다. 어성초 특유의 비린내를 보완할 수 있는 부재료를 첨가하여 맛을 완화시킬 수 있다면 어성초를 이용한 약용주의 개발도 가능할 것으로 판단된다.

• Journal of Electrical Engineering and Technology
• /
• 제12권1호
• /
• pp.78-90
• /
• 2017

This paper presents the design of closed loop controllers operating a single-phase AC-DC three-level converter for improving power quality at AC mains. Closed loop inhibits outer voltage controller and inner current controller. Simulations of three level converter with three different voltage and current controller combinations such as PI-Hysteresis, Fuzzy-Hysteresis and Fuzzy tuned PI-Hysteresis are carried out in MATLAB/Simulink. Performance parameters such as input power factor and source current total harmonic distortion (THD) are considered for comparison of the three controller combinations. The fuzzy-tuned PI voltage controller with hysteresis current controller combination provides a better result, with a source-current THD of 0.93% and unity power factor without any source side filter for the three level converter. For load variations of 25% to 100%, a THD of less than 5% is obtained with a maximum value of only 1.67%. Finally, the fuzzy-tuned PI voltage with hysteresis controller combination is implemented in a Xilinx Spartan-6 XC6SLX25 FPGA board for experimental validation of power quality enhancement. A prototype 100 W, 0-24-48 V as output converter is considered for the testing of controller performance. A source-current THD of 1.351% is obtained in the experimental study with a power factor near unity. For load variations of 25% to 100%, the THD is found to be less than 5%, with a maximum value of only 2.698% in the experimental setup which matches with the simulation results.

• Annals of Surgical Treatment and Research
• /
• 제95권5호
• /
• pp.267-277
• /
• 2018

Purpose: The aim of this study was to analyze survival outcomes in 1,000 consecutive liver transplantations (LTs) performed at a single institution from 1993 to April 2017. Methods: The study population was divided into 2 groups based on donor type: deceased donor LT (DDLT; n = 181, 18.1%) and living donor LT (LDLT; n = 819; 81.9%), and into 3 periods based on the number of cases (first 300 cases, middle 300 cases, last 400 cases). Results: Infection was the most common cause of death, accounting for 34.8% (95 of 273). Mortality due to hepatocellular carcinoma recurrence occurred most frequently between 1 and 5 years after transplantation. Mortality rate by graft rejection was highest between 5 and 10 years after transplantation. And mortality by de novo malignancy occurred most frequently after 10 years after transplantation. The patient survival rates for the entire population at 5 and 10 years were 74.7%, and 68.6%, respectively. There was no difference in survival rate between the LDLT and DDLT groups (P = 0.188). Cause of disease, disease severity, case period, and retransplantation had a significant association with patient survival (P = 0.002, P = 0.031, P = 0.003, and P = 0.024, respectively). Conclusion: Surgical techniques and perioperative management for transplant patients have improved and undergone standardization. Controlling perioperative infection and managing patients with HCC as LT candidates will result in better outcomes.